SCHEMBL4492876

SCHEMBL4492876

Cc1cc(C)nc(NC(=O)c2cc(COc3cccc(Cl)c3)ccn2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.52
KDM4E B2RXH2 2/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
PKM P14618 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
CYP1A2 P05177 2/20 0.51
CYP3A4 P08684 1/20 0.51
CHRNB2 P17787 1/20 0.47
CHRNB4 P30926 1/20 0.47
CHRNA3 P32297 1/20 0.47
CHRNA4 P43681 1/20 0.47
LMNA P02545 2/20 0.47
PRMT5 O14744 1/20 0.46
NPC1 O15118 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
RAB9A P51151 1/20 0.44
MAOA P21397 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4513766 0.89 MAPT (0.48) MAPTKDM4EMEN1KMT2APKM
SCHEMBL4508993 0.87 MRGPRX4 (0.47) MAPTKDM4EMEN1KMT2APKM
SCHEMBL4507587 0.84 SMN1; SMN2 (0.59) MAPTKDM4EMEN1KMT2APKM
SCHEMBL4500386 0.83 MAPT (0.74) MAPTKDM4EMEN1KMT2APKM
SCHEMBL4502419 0.80 MAPT (0.59) MAPTKDM4EMEN1KMT2APKM
SCHEMBL4501168 0.78 MAPT (0.60) MAPTKDM4EMEN1KMT2APKM
SCHEMBL4496717 0.78 MAPT (0.60) MAPTKDM4EMEN1KMT2APKM
SCHEMBL4500253 0.77 RXRA (0.63) PKMCYP1A2NPC1CYP2D6CYP2C9
SCHEMBL4508058 0.76 MAOB (0.51) PKMCYP1A2NPC1CYP2D6CYP2C9
SCHEMBL3424508 0.73 ALDH1A1 (0.64) MAPTKDM4EMEN1KMT2APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090325956-A1 Aromatic amine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325956-A1 Aromatic amine derivative and use thereof SCD, SCD5, SMS MAPT 4022/4885KDM4E 249/4885MEN1 4180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.